Beth Israel Lahey Health’s cover photo
Beth Israel Lahey Health

Beth Israel Lahey Health

Hospitals and Health Care

About us

Beth Israel Lahey Health is a new, integrated system providing patients with better care wherever they are. Care informed by world-class research and education. We are doctors and nurses, technicians and social workers, innovators and educators, and so many others. All with a shared vision for what health care can and should be.

Website
https://www.bilh.org
Industry
Hospitals and Health Care
Company size
10,001+ employees
Type
Nonprofit

Employees at Beth Israel Lahey Health

Updates

  • On this week’s episode of the Healthcare 360 podcast, Dr. Rob Fields speaks with Alex Barker, President of the Beth Israel Lahey Medical Group. With a background in law and experience in the Navy, Alex shares his journey into healthcare leadership, the evolving landscape of medical group management, and his vision for the future of patient care. This episode explores his career path, the challenges of leading a large physician network, and what it takes to drive meaningful change in healthcare. Click here to listen to the full episode ⤵️ https://bit.ly/3RwBRkM

  • At just 41, Kate received an unexpected stage two colon cancer diagnosis. This year, she celebrated her remission by climbing Mt. Washington alongside her care team and is sharing her story to emphasize the importance of regular colorectal cancer screenings. “Don’t wait for the warning signs to get screened. It is one day of your life, and it can save your life.” Read Kate's story⬇️ https://lnkd.in/esVsyUus

  • A trauma surgeon, Dr. Mosenthal is nationally recognized in academic surgery as a pioneer in the field of surgical palliative care. Over the last 25 years, her research and advocacy to integrate palliative care into the care of the critically injured, has changed practice to improve the lives of patients and families. Her commitment to train the next generation of physicians as values-driven leaders has informed the creation of the innovative curriculum at the UMass Chan-Lahey regional medical school. As the founding Executive Dean, she brings a vision to transform the practice of medicine, through the development of physician leaders, who will make a difference into the 21st century and beyond. Thank you, Dr. Mosenthal, for training the next generation of physicians and for your work to improve the lives of patients and families.

    • No alternative text description for this image
  • The Lung Cancer Screening and Lung Nodule Management Programs has been a significant achievement that has led to hundreds of lung cancer diagnoses, the majority of which are early stage and curable due to early detection. Studying and sharing the work regionally and nationally, and building implementation strategies through national leadership roles and collaborations has allowed Dr. Thomson to see "full scale," the impact of this work. She’s inspired by the patients she sees living every day as a result of this work and the achievements of the trainees she has trained in the clinical and scientific approach to this problem. Thank you, Dr. Thomson, for spearheading this incredible work.

    • No alternative text description for this image
  • On this week’s episode of the Healthcare 360 podcast, Dr. Rob Fields speaks with Sandhya Rao, MD, Chief Medical Officer and Senior Vice President at Blue Cross Blue Shield of Massachusetts. Before her current role, Dr. Rao served as the vice president of clinical strategy at Haven, the healthcare organization formed by Amazon, JP Morgan Chase, and Berkshire Hathaway. This episode dives deep into her career journey, the evolving relationship between healthcare providers and payers, and how innovation and collaboration can drive meaningful change in the industry. Click here to listen to the full episode! ⤵️ https://lnkd.in/eGRRfXzJ

  • Chief Academic Officer Dr. Gyongyi Szabo’s research focuses on the role of inflammation in progression of chronic liver diseases to fibrosis, particularly in steatotic liver diseases that are caused by the metabolic syndrome or alcohol consumption. Research from Dr. Szabo's laboratory identified critical immune signaling pathways such as inflammasome activation that are now targets for development of new therapeutics. Here, she talks about what inspires her work. Thank you, Dr. Szabo for your dedication to your colleagues and advancing cancer research and treatment forward.

    • No alternative text description for this image
  • Happy Women’s History Month! We are shining a spotlight on the remarkable academic and research leaders in the BILH community. From Gyongyi Szabo, MD, PhD, to Anne C. Mosenthal, MD, Jennifer Sun, MD, MPH, and Carey C. Thomson, MD, MPH, we are inspired by these incredible women who advance health care and knowledge and strive for excellence every day.

    • No alternative text description for this image

Affiliated pages

Similar pages

Browse jobs